| 產品名稱 | BCL2 Jurkat |
|---|---|
| 商品貨號 | B216413 |
| Organism | Homo sapiens, human |
| Tissue | peripheral blood |
| Cell Type | T Cell/ T Lymphocyte |
| Product Format | frozen |
| Morphology | lymphoid-like |
| Culture Properties | suspension |
| Biosafety Level | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease | acute T cell leukemia |
| Age | 14 years |
| Gender | male |
| Applications | This cell line over-expresses BCL-2, and is useful to study cell apoptosis, BCL-2 function and its pathway. |
| Storage Conditions | liquid nitrogen vapor phase |
| Images |  |
| Derivation | The BCL2 Jurkat cell line was derived by transfecting human Jurkat T cells with the pSFFV-neo mammalian expression vector containing the human BCL-2 ORF insert and a neomycin-resistant gene (Addgene # 3349). Stable neomycin (Neo)-resistant single-cell-originated clones were isolated and expanded by selection in medium containing 1 mg/mL G418 for 14 days (1). |
| Cellular Products | Neomycin resistance gene, expressed BCL2 over-expressed, verified at ATCC |
| Tumorigenic | Yes |
| Comments | The BCL2 Jurkat cell line was derived by transfecting human Jurkat T cells with the pSFFV-neo mammalian expression vector containing the human BCL-2 ORF insert and a neomycin-resistant gene (Addgene # 3349). Stable neomycin (Neo)-resistant single-cell-originated clones were isolated and expanded by selection in medium containing 1 mg/mL G418 for 14 days (1). The BCL2 Jurkat cell line produces over-expression of human BCL-2. |
| Complete Growth Medium | The base medium for this cell line is ATCC-formulated RPMI-1640 Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: 10% FBS and 200 mcg/mL G418.
|
| Subculturing | Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension in fresh medium. An inoculum of 2 x 105 to 3 x 105 cells/mL is recommended. Subculture when cell concentration is 2 x 106 cells/mL. Subcultivation ratio: A subcultivation ratio of 1:2 to 1:10 is recommended.Medium renewal: Add fresh medium every 2 to 3 days (depending on cell density) |
| Cryopreservation | Freeze medium: 90% Fetal Bovine Serum and 10% DMSO Storage temperature: liquid nitrogen vapor phase |
| Culture Conditions | Temperature: 37°C Atmosphere: air, 95%; carbon dioxide (CO2), 5% |
| STR Profile | D5S818: 9 D13S317: 8, 12 D7S820: 8, 12 D16S539: 11 vWA: 18, 19 TH01: 6, 9.3 Amelogenin: X Y TPOX: 8, 10 CSF1PO: 11, 12 |
| Name of Depositor | Stanley Korsmeyer |
| Year of Origin | 2003 |
| References | Yamamoto K, et al. BCL-2 is Phosphorylated and Inactivated by an ASK1/Jun N-Terminal Protein Kinase Pathway normally Activated at G2/M. Mol Cell Biol. Dec;19(12):8469-78. 1999. PubMed: 10567572 |
| 梅經理 | 17280875617 | 1438578920 |
| 胡經理 | 13345964880 | 2438244627 |
| 周經理 | 17757487661 | 1296385441 |
| 于經理 | 18067160830 | 2088210172 |
| 沈經理 | 19548299266 | 2662369050 |
| 李經理 | 13626845108 | 972239479 |
